Future of COX2 inhibitors

Nature Reviews Drug Discovery

Volumn 4, Issue 6, 2005, Pages 453-454

  Melnikova, Irena ^a  

^a MEDACorp   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETORICOXIB; FENOPROFEN; FLURBIPROFEN; IBUPROFEN; INDOMETACIN; KETOPROFEN; LUMIRACOXIB; MEFENAMIC ACID; MUSCLE RELAXANT AGENT; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PARECOXIB; PIROXICAM; PLACEBO; ROFECOXIB; SULINDAC SULFIDE; TUMOR NECROSIS FACTOR ANTIBODY; VALDECOXIB;

ARTHRITIS; CARDIOTOXICITY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COLON ADENOMA; DRUG EFFICACY; DRUG LABELING; DRUG MARKETING; DRUG SAFETY; DRUG WITHDRAWAL; FOOD AND DRUG ADMINISTRATION; GASTROINTESTINAL SYMPTOM; HEART INFARCTION; HUMAN; INCIDENCE; INFLAMMATION; NOTE; PAIN; PRIORITY JOURNAL; UNITED KINGDOM; UNITED STATES;

CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DRUG INDUSTRY; FORECASTING; HUMANS; MARKETING; MEMBRANE PROTEINS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;

EID: 20844456628     PISSN: 14741776     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrd1755     Document Type: Note

References (3)

1. FitzGerald, G. COX2 and beyond: Approaches to prostaglandin inhibition in human disease. Nature Rev. Drug Discov. 2, 879-890 (2003).
2. Drazen, J. M. COX-2 inhibitors - a lesson in unexpected problems. N. Engl. J. Med. 352, 1131-1132 (2005).
3. Psaty, B. M. et al. Cox-2 inhibitors - lessons in drug safety. N. Engl. J. Med. 352, 1133-1135 (2005).